| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 176.55B | 175.42B | 152.86B | 132.81B | 118.43B | 113.60B |
| Gross Profit | 80.50B | 78.91B | 68.95B | 60.26B | 53.55B | 49.84B |
| EBITDA | 34.20B | 34.53B | 30.12B | 25.12B | 21.32B | 18.69B |
| Net Income | 16.53B | 17.83B | 13.14B | 11.29B | 9.73B | 7.25B |
Balance Sheet | ||||||
| Total Assets | 183.87B | 194.34B | 184.59B | 171.25B | 159.34B | 150.56B |
| Cash, Cash Equivalents and Short-Term Investments | 57.08B | 67.82B | 65.30B | 65.76B | 63.56B | 58.99B |
| Total Debt | 13.57B | 15.33B | 13.86B | 12.21B | 8.97B | 8.22B |
| Total Liabilities | 52.47B | 57.77B | 56.48B | 49.61B | 43.07B | 38.97B |
| Stockholders Equity | 130.87B | 135.93B | 127.60B | 120.76B | 115.52B | 110.85B |
Cash Flow | ||||||
| Free Cash Flow | 18.30B | 20.11B | 20.35B | 16.16B | 17.25B | 13.20B |
| Operating Cash Flow | 23.21B | 24.67B | 23.77B | 18.95B | 19.20B | 15.60B |
| Investing Cash Flow | -9.87B | -4.19B | -10.22B | -7.38B | -5.89B | -6.36B |
| Financing Cash Flow | -22.26B | -17.36B | -18.22B | -13.95B | -10.87B | -8.63B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥94.15B | 13.80 | ― | 1.68% | 2.72% | 33.10% | |
80 Outperform | ¥66.74B | 8.26 | ― | 2.31% | 6.50% | 30.54% | |
79 Outperform | ¥98.94B | 15.13 | ― | 3.23% | 7.28% | 4.16% | |
77 Outperform | ¥292.57B | 17.58 | ― | 1.49% | 18.20% | 28.13% | |
76 Outperform | ¥42.21B | 4.58 | 6.12% | 2.67% | -7.95% | -34.83% | |
75 Outperform | ¥260.89B | 17.60 | 12.72% | 4.21% | 4.91% | 18.45% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |